Tianjin Medical University

Tianjin, China

Tianjin Medical University (TMU), established in 1951, is China's first medical institution approved by the State Council, renowned for its excellence in medical education and research. Recognized under China's "Double First-Class" initiative
Add to compare
7.1k
5.2k
1.9k
0

Tuition Fees, Cost of Living & Accommodation at Tianjin Medical University

Cost Of Living

¥ 27600

Undergraduate Fees International Students

¥ 47000

Post Graduate Fees International Students

¥ 51600

Bachelors

  • ¥ 47000
  • ¥ 47000
  • ¥ 47000
  • ¥ 47000
  • ¥ 47000

Tianjin Medical University Departments

  • Department of Clinical Medicine
  • Department of Traditional Chinese Medicine
  • Department of Medical Imaging
  • Department of Surgery
  • Department of Neurology
  • Department of Oncology
  • Department of Endocrinology
  • Department of Microbiology
  • Department of Immunology
  • Department of Cardiovascular Diseases

Distinguished Alumni of Tianjin Medical University

Step-by-Step Guide to Admission Requirements at Tianjin Medical University

Admission requirements for the Bachelor's programs at Tianjin Medical University (TMU):

Educational Background: Applicants must possess a senior high school diploma or its equivalent, with excellent academic performance. 

Age Limit: Candidates should be under the age of 25 at the time of application. 

Language Proficiency: For English-taught programs, a minimum TOEFL score of 80 or IELTS score of 6.0 is required.

Health Requirements: Applicants must be in good physical and mental health, and provide a health check report. 

Criminal Record: A non-criminal report from the local police station is necessary. 

Supporting Documents: Applicants must submit a recent passport-sized photo, photocopy of a valid passport, high school graduation certificate, high school academic transcripts, and a self-statement of at least 300 words. 

 

Know more

Tianjin Medical University Corporate Partnership

  • Baxter Medical : In 2024, Baxter Medical Equipment (Shanghai) Co., Ltd. collaborated with Tsinghua University Tianjin High-end Equipment Research Institute to advance China's smart ward development. This partnership focuses on integrating cutting-edge technology and experience in intelligent medical equipment to promote the intelligent development and innovation of China's medical model
  • Lund University : TMU's Cancer Institute & Hospital signed a scientific cooperation agreement with Lund University in 2012 to develop new biomarkers for the early diagnosis and prevention of pancreatic, breast, and ovarian cancers. The collaboration has facilitated joint research and data analysis, contributing to advancements in cancer diagnostics
  • Kobe University : In 2020, TMU and Kobe University signed an inter-institutional Memorandum of Understanding to enhance collaboration in personnel cultivation, teacher and doctor training, and research. This partnership aims to strengthen academic and clinical exchanges between the two institutions
  • Nankai University : TMU and Nankai University have a long-standing collaboration dating back to the 1950s. In 2020, the two universities co-founded the Tianjin Joint Research Institute of Public Health, focusing on public health and global health research. This institute serves as a high-level talent training base and a platform for scientific research achievements
  • The University of Texas MD Anderson Cancer Center : In 2006, TMU's Cancer Institute & Hospital and The University of Texas MD Anderson Cancer Center expanded their collaboration to include clinical, educational, and translational cancer research. This partnership aims to develop joint programs supporting the shared mission of eradicating cancer worldwide through scientific discovery and advanced patient therapies
  • PolyU (The Hong Kong Polytechnic University) : In 2023, TMU and PolyU established a scientific collaborative research platform focusing on identifying the causes of eye diseases and constructing a screening system. The partnership combines PolyU's research capabilities with TMU's clinical expertise to advance ophthalmic research and technology.
  • Tianjin Pharmaceutical Group : TMU's Key Laboratory has established cooperation with large pharmaceutical companies in Tianjin, including Tianjin Pharmaceutical Group, to promote developments in biomedical science and industries. This collaboration aims to integrate medical science and drug development, facilitating the transformation of achievements and enhancing the biomedical industry's competitiveness
  • Tasly Pharmaceutical Group : TMU's Key Laboratory has also partnered with Tasly Pharmaceutical Group to advance biomedical research and development. This collaboration focuses on integrating medical science and drug development, aiming to promote the growth of the biomedical industry and the transformation of scientific achievements
View More

Notable Achievements of Tianjin Medical University

Achievements

01.
Discovery of Bone Marrow Immunity's Role in Multiple Sclerosis

In 2022, Professor Liu Qiang's team at TMU made a groundbreaking discovery identifying bone marrow immunity as a new target for multiple sclerosis (MS) treatment. Their research, published in the prestigious journal Cell, provided novel insights into the autoimmune mechanisms of MS, paving the way for innovative therapeutic approaches.

Year
2022
02.
Accreditation of Clinical Medicine in ESI Top 1‰

TMU's Clinical Medicine discipline has been ranked in the top 0.1% globally by Essential Science Indicators (ESI), reflecting the university's high-impact research and academic excellence in the medical field.

Year
2022
03.
Collaboration with AstraZeneca on Cardiovascular Research

TMU entered into a research collaboration with AstraZeneca to explore novel targets against cardiac fibrosis, a major contributor to heart failure. This partnership focuses on understanding the mechanisms of fibrosis and developing potential therapeutic interventions, demonstrating TMU's commitment to addressing global health challenges

Year
2021

Notable Innovation, Research & Development Tianjin Medical University

Notable Innovation

01.
Discovery of Bone Marrow Immunity's Role in Multiple Sclerosis

In 2022, Professor Liu Qiang's team at TMU made a significant discovery regarding the role of bone marrow immunity in multiple sclerosis (MS). Their research identified bone marrow as a new target for MS treatment, providing insights into the autoimmune mechanisms of the disease. This breakthrough was published in the prestigious journal Cell, highlighting TMU's contribution to understanding and potentially treating MS

Year
2022
02.
Chronic Subdural Hematoma Atorvastatin Therapy

TMU's neurosurgery team introduced a novel therapy for chronic subdural hematoma using atorvastatin. This treatment approach has changed the management of the disease, offering a non-surgical option that reduces recurrence rates and improves patient outcomes. The therapy underscores TMU's role in advancing neurosurgical treatments through pharmacological innovations

Year
2022
03.
Hydrophilic Spherical Foldable Intraocular Lens

TMU's Eye Hospital collaborated in developing a hydrophilic spherical foldable intraocular lens, which won the third prize of the Tianjin Science and Technology Progress Award in 2022. This lens improves postoperative visual outcomes for cataract patients, reflecting TMU's commitment to advancing ophthalmic surgical devices

Year
2022

University Ranking of Tianjin Medical University

501-600
1248

Region: Asia

101
309
Medicine
-
423
-
-
Radiology
-
199
-
-
Pharmaceutical Toxicology
-
241
-
-
Oncology
-
126
-
-

Connect With Tianjin Medical University

  • 22 Qixiangtai Road

Book Free Session with Our Admission Experts

Admission Experts